@FierceMedDev: Boston Scientific's Q3 2012 earnings report has very few bright spots, as restructuring continues. More | Follow @FierceMedDev
@MarkHFierce: Computer viruses are running wild in hospital medical devices, MIT Technology Review reports. More | Follow @MarkHFierce
@DamianFierce: Stryker is scaling back its profit projections after a disappointing third quarter. More | Follow @DamianFierce
> Abbott Laboratories ($ABT) has laid off an additional 550 people, affecting its diagnostic, medical devices, pharmaceutical and nutrition units. Story
> Paradigm Spine gained FDA approval for a device designed to treat moderate to severe spinal stenosis whether or not back pain is involved. Item
> Helix Medical, a medical device and healthcare industry manufacturer, has acquired MedVenture Technology from private equity firm Ampersand Capital Partners. MedVenture designs, develops and makes medical devices. Neither side disclosed financial terms. Release
> A man with Duchenne muscular dystrophy is among the first U.S. patients with the disease to receive a ventricular assist device. Item
> Neuro Kinetics won a new $2.4 million Department of Defense grant to develop new diagnostic tests for brain injuries stemming from combat. Story
> Device maker Tornier ($TRNX) will announce its 2012 third quarter earnings on Monday, Nov. 5, 2012. Release
> EarlySense gained FDA approval for its new oximetry bedside monitor. Story
> LabCorp ($LH) again reduced its 2012 profit outlook after posting meager growth in the third quarter. Article
Biotech News
@FierceBiotech: The ax drops on hundreds at Human Genome Sciences in wake of GSK buyout. More | Follow @FierceBiotech
@JohnCFierce: FDA is extending review of BG-12 (MS). Drat. Thought we'd have an approval this year. Big drug for Biogen. More | Follow @JohnCFierce
> BioCryst scoops up early-stage hep C drugs in $101M Presidio acquisition. Article
> Aegerion wins lopsided FDA panel vote backing rare cholesterol disease drug. News
> Abbott slammed after deaths scuttle PhIII kidney disease program. Story
> Actelion abstract details 'promising' macitentan data. Item
Pharma News
@FiercePharma: NYT explores the sorry state of some pharma manufacturing plants--and their contributions to drug shortages. More | Follow @FiercePharma
> Abbott adds 550 to layoffs toll as split-up nears. Story
> Facing Monday trial, Pfizer settles bellwether Chantix case. Article
> Teva, HGS beef up layoff plans in U.S. News
Vaccines News
> J. Craig Venter explores printable vaccines. Article
> GSK recalls infant vaccine in Australia. Story
> University of Minnesota researchers call for better flu vaccine. More
> Study: HPV vaccine does not increase signs of sexual activity. More
> Special Report: 10 promising therapeutic vaccines 2012. Report
Pharma Manufacturing News
> Ben Venue begins limited manufacturing at Ohio drug plant. News
> Criminal investigators search site linked to meningitis outbreak. Report
> Watson to sell manufacturing tech to seal $5.9B Actavis deal. Story
> FDA warns stem cell outfit Celltex about GMP no-nos. Article